ESC

This channel contains news about the European Society of Cardiology (ESC), including coverage of its annual meeting and new guidelines. ESC is a leading resource for cardiology science and information in Europe.

DANFLU-1 trial presented in a Hot Line Session at ESC Congress 2022

News | Cardiac Imaging

Innovative Randomized Trial Hints at Mortality Benefits with High-Dose Influenza Vaccines

September 2, 2022 — In an innovative, pragmatic randomized trial, high-dose influenza vaccination in older adults was ...

September 02, 2022

News | Artificial Intelligence

Artificial Intelligence Assessment of Heart Function is Superior to Sonographer Assessment

September 2, 2022 — In patients undergoing echocardiographic evaluation of cardiac function, preliminary assessment by a ...

September 02, 2022

REVIVED-BCIS2 trial presented in a Hot Line Session today at ESC Congress 2022

News | Heart Failure

Coronary Stenting Does Not Benefit Patients with Severe Left Ventricular Dysfunction

September 2, 2022 — Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospit ...

September 02, 2022

More than 30,271 health professionals from 174 countries attended this year’s event, which covered the entire field of cardiovascular medicine at ESC22

News | ESC

Best of ESC Congress 2022

September 1, 2022 — “At ESC Congress in Barcelona, we discussed the newest science in the light of our collective ...

September 01, 2022

Comatose patients admitted to hospital after resuscitation from out-of-hospital cardiac arrest have a significant risk of death and poor neurological outcome due to hypoxic brain injury.

News | Sudden Cardiac Arrest

Trial Finds no Benefit of Raising Blood Pressure Target in Post Cardiac Arrest Patients

September 1, 2022 — A target blood pressure of 77 mmHg provides no benefit to survival or neurological outcome in ...

September 01, 2022

ALL-HEART trial presented in a Hot Line Session at ESC Congress 2022

News | Stroke

Allopurinol Does Not Improve Cardiovascular Outcomes in Ischaemic Heart Disease Patients

September 1, 2022 — The gout medicine allopurinol has failed to reduce the primary endpoint of nonfatal myocardial ...

September 01, 2022

A clinician using Ultrasound Workspace from Philips

News | ESC

Philips Spotlights Integrated, Data-Driven Cardiology Solutions at ESC 2022

August 30, 2022 — Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, will showcase its latest ...

August 30, 2022

SECURE trial presented in a Hot Line Session today at ESC Congress 2022

News | ESC

Polypill Reduces Cardiovascular Events in Heart Attack Patients Compared to Usual Care

August 30, 2022 — A pill containing aspirin and medications to lower lipids and blood pressure more effectively prevents ...

August 30, 2022

The MOMENTUM 3 study showcases the significant survival benefits of Abbott's heart pump technology, particularly in a patient population with limited therapy options

News | ESC

New Data Show Abbott's Heartmate 3 Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients

August 30, 2022 — Abbott announced new late-breaking data that show its HeartMate 3 heart pump extends survival of advan ...

August 30, 2022

Late-breaking data presented at ESC Congress 2022 and simultaneously published in The New England Journal of Medicine confirms implant procedure safety and defibrillation success

News | Heart Failure

FARXIGA Significantly Reduced the Risk of Cardiovascular Death or Worsening of Heart Failure in Patients with Mildly Reduced or Preserved Ejection Fraction in DELIVER Phase III Trial

August 29, 2022 — Detailed results from the DELIVER Phase III trial showed AstraZeneca’s FARXIGA (dapagliflozin) ...

August 29, 2022

News | Implantable Cardioverter Defibrillator (ICD)

Medtronic Extravascular ICD meets global pivotal clinical trial’s safety and effectiveness endpoints

August 29, 2022 — Medtronic plc announced that its investigational EV ICD System – a first-of-its-kind defibrillator ...

August 29, 2022

Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) significantly reduced cardiovascular (CV) events in patients with a history of smoking.

News | ESC

New REDUCE-IT Data Released at ESC Oral Presentation Session

August 29, 2022 — Amarin Corporation plc announced that new REDUCE-IT data show that VASCEPA/VAZKEPA (icosapent ethyl) ...

August 29, 2022

A study from the Smidt Heart Institute and Cedars-Sinai's Division of Artificial Intelligence in Medicine shows that AI was more accurate in diagnosing cardiac function than sonographers. Illustration by Getty.

News | Artificial Intelligence

Late-Breaking Heart Research: AI More Accurate Than Technicians

August 29, 2022 — In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and ...

August 29, 2022

News | ESC

ESC Congress 2022 Announces Hot Line Sessions

Organizers of the European Society of Cardiology (ESC) Congress have released plans and announced 10 Hot Line ...

July 22, 2022

Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according to a review paper published today in Cardiovascular Research

News | Heart Failure

Scientists Warn of Links Between Soil Pollution and Heart Disease

July 12, 2022 — Pesticides and heavy metals in soil may have detrimental effects on the cardiovascular system, according ...

July 12, 2022